Holen Sie sich die Stockscreener-App
3.035
24.50%
0.595
Schlusskurs vom Vortag:
$2.44
Offen:
$3.01
24-Stunden-Volumen:
45.22M
Relative Volume:
8.86
Marktkapitalisierung:
$1.62M
Einnahmen:
$1.31M
Nettoeinkommen (Verlust:
$-7.47M
KGV:
-0.4208
EPS:
-7.2117
Netto-Cashflow:
$-5.11M
1W Leistung:
+23.49%
1M Leistung:
-24.43%
6M Leistung:
+887.93%
1J Leistung:
+1,242%
1-Tages-Spanne:
$2.84
$3.3199
1-Wochen-Bereich:
$2.25
$3.3199
52-Wochen-Spanne:
$0.197
$8.90
Scisparc Ltd Stock (SPRC) Company Profile
Vergleichen Sie SPRC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SPRC
Scisparc Ltd
|
3.03 | 3.96M | 1.31M | -7.47M | -5.11M | -7.2117 |
|
VRTX
Vertex Pharmaceuticals Inc
|
430.05 | 109.05B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
785.96 | 82.75B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
442.15 | 56.78B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
924.75 | 56.52B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.59 | 44.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Scisparc Ltd Aktie (SPRC) Neueste Nachrichten
SciSparc’s Patent Surge: Buy or Hold? - StocksToTrade
Why SciSparc Stock Is Gaining Today - Benzinga
SciSparc Shares Surge After Company Moves to Acquire GERD Treatment Technology - MSN
SciSparc stock soars after acquiring GERD treatment technology - Investing.com
SciSparc to acquire treasury of patents for medical endoscopy systems - TipRanks
SciSparc to acquire MUSE endoscopic system patents from Xylo By Investing.com - Investing.com India
SciSparc to acquire endoscopic system patents from Xylo Technologies By Investing.com - Investing.com South Africa
Scisparc shares climb 27.5% premarket; co says will buy a treasury of patents, trademarks and intellectual property rights from Xylo - MarketScreener
SciSparc Ltd. Signs Agreement to Acquire Patent and Intellectual Property Portfolio for Innovative MUSE™ Endoscopic System from Xylo Technologies Ltd. - Quiver Quantitative
SciSparc (Nasdaq: SPRC) to acquire MUSE GERD device IP for 19.99% equity - Stock Titan
SciSparc Stock Soars Pre-Market After Snapping Up Patents For Next-Gen Endoscopy Tech - Stocktwits
SciSparc, Clearmind Medicine file Israeli patent application for depression - MSN
SciSparc Ltd. (SPRC) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Will SciSparc Ltd. stock recover faster than peersGlobal Markets & Risk Managed Investment Signals - newser.com
How SciSparc Ltd. stock compares to industry benchmarksJuly 2025 Weekly Recap & Technical Buy Zone Confirmations - newser.com
SciSparc Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
SciSparc Announces New Patent Filing for Depression Treatment - TipRanks
Today's SEC FilingsLatest 10-K, 10-Q, 8-K Forms - Stock Titan
[6-K] SciSparc Ltd. Current Report (Foreign Issuer) | SPRC SEC FilingForm 6-K - Stock Titan
SciSparc subsidiary files patent for depression treatment combination By Investing.com - Investing.com Australia
SciSparc subsidiary files patent for depression treatment combination - Investing.com
SciSparc: Neurothera Labs Announces Israeli Patent Application in Collaboration with Clearmind Medicine for Novel Non-Hallucinogenic Neuroplastogen Treatment for Depression - The Manila Times
SciSparc Ltd. Partner NeuroThera Labs Advances Depression Treatment with New Patent Application for Combination Therapy - Quiver Quantitative
SciSparc (Nasdaq: SPRC) Supports NeuroThera Israeli Patent for MEAI-PEA Depression Therapy - Stock Titan
Will SciSparc Ltd. stock gain from lower inflationWeekly Profit Summary & Weekly High Potential Stock Alerts - newser.com
Is SciSparc Ltd. stock entering bullish territoryJuly 2025 Selloffs & Verified Trade Idea Suggestions - newser.com
Is SciSparc Ltd. stock in correction or buying zone2025 Support & Resistance & Verified Swing Trading Watchlists - newser.com
Is SciSparc Ltd. stock a top momentum playMarket Risk Summary & Capital Efficient Trading Techniques - newser.com
SciSparc Ltd. Releases Interim Financial Results for H1 2025 - MSN
How SciSparc Ltd. stock performs in interest rate cyclesJuly 2025 Earnings & Verified Momentum Watchlists - newser.com
What analysts say about SciSparc Ltd stockLong-Term Growth Stocks & Discover Stocks Experts Are Watching - earlytimes.in
Will SciSparc Ltd. bounce back from current supportJuly 2025 Setups & Fast Entry High Yield Tips - newser.com
SciSparc Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025 - MarketScreener
Scisparc Ltd. Net Worth (2025) - GuruFocus
SciSparc, AutoMax Motors mutually agree to terminate merger - MSN
Finanzdaten der Scisparc Ltd-Aktie (SPRC)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.46%
1.53%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):